Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
D002283:Carcinoma, Bronchogenic / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D012189:Retrospective Studies; D013557:Switzerland; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate